Minna Sjöroos

1.4k total citations
21 papers, 1.1k citations indexed

About

Minna Sjöroos is a scholar working on Genetics, Surgery and Immunology. According to data from OpenAlex, Minna Sjöroos has authored 21 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 8 papers in Surgery and 8 papers in Immunology. Recurrent topics in Minna Sjöroos's work include Diabetes and associated disorders (12 papers), Pancreatic function and diabetes (8 papers) and T-cell and B-cell Immunology (6 papers). Minna Sjöroos is often cited by papers focused on Diabetes and associated disorders (12 papers), Pancreatic function and diabetes (8 papers) and T-cell and B-cell Immunology (6 papers). Minna Sjöroos collaborates with scholars based in Finland, Estonia and Sweden. Minna Sjöroos's co-authors include Jorma Ilonen, Timo Lövgren, Mikael Knip, Helena Reijonen, Olli Simell, Antti Iitiä, Sari Korhonen, Tuula Simell, Teija Kimpimäki and Antti Kupila and has published in prestigious journals such as Diabetes Care, Diabetes and Analytical Biochemistry.

In The Last Decade

Minna Sjöroos

21 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Minna Sjöroos Finland 15 742 526 491 210 134 21 1.1k
A. K. Foulis United Kingdom 11 614 0.8× 422 0.8× 300 0.6× 362 1.7× 94 0.7× 19 1.0k
Marshall Austin United States 6 561 0.8× 321 0.6× 250 0.5× 209 1.0× 81 0.6× 6 857
Jacqueline D. Trudeau Canada 12 508 0.7× 343 0.7× 182 0.4× 509 2.4× 83 0.6× 23 1.0k
Maria Kanariou Greece 19 255 0.3× 124 0.2× 96 0.2× 300 1.4× 154 1.1× 54 869
H Müntefering Germany 13 184 0.2× 266 0.5× 40 0.1× 76 0.4× 230 1.7× 47 769
B. B. Scott United Kingdom 12 375 0.5× 168 0.3× 39 0.1× 185 0.9× 147 1.1× 18 926
S. Bousnina Tunisia 10 139 0.2× 193 0.4× 198 0.4× 20 0.1× 142 1.1× 68 570
David F. Hutcheon United States 14 446 0.6× 325 0.6× 94 0.2× 26 0.1× 676 5.0× 22 1.5k
Juan Carlos Vitoria Spain 22 372 0.5× 528 1.0× 59 0.1× 345 1.6× 87 0.6× 50 1.3k
Henrik Gjertsen Sweden 14 143 0.2× 223 0.4× 35 0.1× 108 0.5× 174 1.3× 28 766

Countries citing papers authored by Minna Sjöroos

Since Specialization
Citations

This map shows the geographic impact of Minna Sjöroos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minna Sjöroos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minna Sjöroos more than expected).

Fields of papers citing papers by Minna Sjöroos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minna Sjöroos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minna Sjöroos. The network helps show where Minna Sjöroos may publish in the future.

Co-authorship network of co-authors of Minna Sjöroos

This figure shows the co-authorship network connecting the top 25 collaborators of Minna Sjöroos. A scholar is included among the top collaborators of Minna Sjöroos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minna Sjöroos. Minna Sjöroos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hauache, O.M., et al.. (2005). The Ala45Thr polymorphism of NEUROD1 is associated with type 1 diabetes in Brazilian women. Diabetes & Metabolism. 31(6). 599–602. 5 indexed citations
2.
Laine, Antti‐Pekka, Sergei Nejentsev, Riitta Veijola, et al.. (2004). A linkage study of 12 IDDM susceptibility loci in the Finnish population. Diabetes/Metabolism Research and Reviews. 20(2). 144–149. 12 indexed citations
3.
Laaksonen, Mikko, Tomi Pastinen, Minna Sjöroos, et al.. (2002). HLA class II associated risk and protection against multiple sclerosis—a Finnish family study. Journal of Neuroimmunology. 122(1-2). 140–145. 59 indexed citations
4.
Ilonen, Jorma, Minna Sjöroos, Mikael Knip, et al.. (2002). Estimation of genetic risk for type 1 diabetes. American Journal of Medical Genetics. 115(1). 30–36. 46 indexed citations
5.
Kupila, Antti, Päivi Keskinen, Tuula Simell, et al.. (2002). Genetic Risk Determines the Emergence of Diabetes-Associated Autoantibodies in Young Children. Diabetes. 51(3). 646–651. 54 indexed citations
6.
Nurmi, Jussi, et al.. (2001). High-Throughput Genetic Analysis Using Time-Resolved Fluorometry and Closed-Tube Detection. Analytical Biochemistry. 299(2). 211–217. 18 indexed citations
7.
Kupila, Antti, P Muona, Tuula Simell, et al.. (2001). Feasibility of genetic and immunological prediction of Type I diabetes in a population-based birth cohort. Diabetologia. 44(3). 290–297. 268 indexed citations
8.
Sjöroos, Minna, Jorma Ilonen, & Timo Lövgren. (2001). Solid-Phase PCR with Hybridization and Time-resolved Fluorometry for Detection of HLA-B27. Clinical Chemistry. 47(3). 498–504. 13 indexed citations
9.
Sjöroos, Minna, Jorma Ilonen, & Timo Lövgren. (2001). Solid-phase PCR with hybridization and time-resolved fluorometry for detection of HLA-B27.. PubMed. 47(3). 498–504. 14 indexed citations
10.
Kulmala, Petri, K. Savola, Paula Vähäsalo, et al.. (2000). Stability of autoantibodies and their relation to genetic and metabolic markers of Type I diabetes in initially unaffected schoolchildren. Diabetologia. 43(4). 457–464. 21 indexed citations
11.
Nejentsev, Sergei, Minna Sjöroos, Mikael Knip, et al.. (1999). Population‐based genetic screening for the estimation of Type 1 diabetes mellitus risk in Finland: selective genotyping of markers in the HLA‐DQB1, HLA‐DQA1 and HLA‐DRB1 loci. Diabetic Medicine. 16(12). 985–992. 126 indexed citations
12.
Sjöroos, Minna, Mika J. Mäkelä, Matti Waris, et al.. (1999). SIMULTANEOUS DETECTION OF IFN-γ AND IL-4 mRNAS USING RT-PCR AND TIME-RESOLVED FLUOROMETRY. Cytokine. 11(1). 87–93. 14 indexed citations
13.
Sjöroos, Minna, Åke Lundwall, Matti Karp, et al.. (1999). Quantitative Reverse Transcription-PCR Assay with an Internal Standard for the Detection of Prostate-specific Antigen mRNA. Clinical Chemistry. 45(9). 1397–1407. 35 indexed citations
14.
Sjöroos, Minna, et al.. (1998). Detection of HLA-B27 alleles by group-specific amplification and time-resolved fluorometry. Journal of Immunological Methods. 219(1-2). 131–137. 17 indexed citations
15.
Nejentsev, Sergei, Minna Sjöroos, Helena Reijonen, et al.. (1998). Distribution of insulin‐dependent diabetes mellitus (IDDM)‐related HLA alleles correlates with the difference in IDDM incidence in four populations of the Eastern Baltic region. Tissue Antigens. 52(5). 473–477. 30 indexed citations
16.
Sjöroos, Minna, Jorma Ilonen, Helena Reijonen, & Timo Lövgren. (1998). Time‐Resolved Fluorometry Based Sandwich Hybridisation Assay for HLA‐DQA1 Typing. Disease Markers. 14(1). 9–19. 28 indexed citations
17.
Ilonen, Jorma, Sinikka Koskinen, Sergey Nejentsev, et al.. (1997). HLA‐DQB1*0304‐DRB1*0408 haplotype associated with insulin–dependent diabetes mellitus in populations in the eastern Baltic region. Tissue Antigens. 49(5). 532–534. 7 indexed citations
18.
Sjöroos, Minna, et al.. (1996). HLA-DQB1 genotypes associated with IDDM risk in healthy school children positive for GAD65 and islet cell antibodies. Human Immunology. 47(1-2). 152–152. 5 indexed citations
19.
Ilonen, Jorma, Helena Reijonen, Elja Herva, et al.. (1996). Rapid HLA-DQB1 Genotyping for Four Alleles in the Assessment of Risk for IDDM in the Finnish Population. Diabetes Care. 19(8). 795–800. 114 indexed citations
20.
Sjöroos, Minna, Antti Iitiä, Jorma Ilonen, Helena Reijonen, & Timo Lövgren. (1995). Triple-label hybridization assay for type-1 diabetes-related HLA alleles.. PubMed. 18(5). 870–7. 145 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. K. Foulis Breakdown of academic impact, for papers by Marshall Austin Breakdown of academic impact, for papers by Jacqueline D. Trudeau Breakdown of academic impact, for papers by Maria Kanariou Breakdown of academic impact, for papers by H Müntefering Breakdown of academic impact, for papers by B. B. Scott Breakdown of academic impact, for papers by S. Bousnina Breakdown of academic impact, for papers by David F. Hutcheon Breakdown of academic impact, for papers by Juan Carlos Vitoria Breakdown of academic impact, for papers by Henrik Gjertsen
Rankless by CCL
2026